The global sperm density testing market is forecast to be valued at US$ 990 million in 2023, and will likely expand at a CAGR of 6% until 2033, as per a recently published market research report by Future Market Insights. According to the study, the market for sperm density testing is further poised to reach US$ 1,733 million by the end of the 2023-2033 period of assessment. The need for sperm density testing has been accentuated by the prevalence of highly sedentary lifestyles, leading to mounting infertility problems among men.
As per the Centers for Disease Control and Prevention (CDC), 9% of men aged 15 to 44 suffer from infertility. Overall, across all age groups, the incidence rate is as high as 30%. Infertility causes substantial psychological and social distress and imposes a considerable economic burden on patients and healthcare systems. Hence, early diagnosis and treatment are of utmost importance. Male infertility is increasingly recognized as a marker for overall male health. It has been associated with premature deaths, cancer, and other comorbid medical conditions.
Male infertility is of two types- the first includes problems with the actual process of sexual intercourse, while the second includes problems with the sperm. In the latter case, the key culprits involve obesity, smoking or tobacco ingestion, excessive alcohol consumption, wearing tight-fitting underwear, consumption of anabolic steroids, vasectomies, and consumption of recreational drugs.
The problem is especially overt across the developed world, which is why a majority of growth opportunities for key treatment providers are likely to set up bases across Europe and North America. A study presented at the American Society for Reproductive Medicine (ASRM) summit in 2018 revealed that the percentage of nearly 120,000 male infertility patients whose total motile sperm count numbered more than 15 million, decreased from 85% in the period ranging from 2002 to 2005 to 79% in the period of 2014 to 2017. Furthermore, it is apprehended that most men in the United States and Europe could be infertile by 2060.
Realizing the magnitude of the problem, governments are actively promoting awareness campaigns, undertaking extensive research studies, and sanctioning breakthrough therapies and treatment approaches to ascertain sperm density. In 2017, California-based Sandstone Diagnostics introduced the Trak Male Fertility Testing System, an FDA-approved device that uses centrifugal force to separate and quantify sperm cells. The at-home testing device gives men the opportunity to check their sperm count and improve reproductive health. Trak comes with 4 test packets, and two-pack refills are also available for purchase. Through the Trak app, men can log their results and track their progress over time.
Likewise, ExSeed Health offers sperm test kits for home use. The test provides results within a time span of 15 minutes, is more than 95% accurate, with a CE certification, helps improve sperm count with a personalized in-app program, and poses no risk of sample damage on the way to the lab. The test is W.H.O certified and used advanced fertility technology to determine the sperm count and suggest measures. In addition, the device allows for the sperm to be magnified 200x using the smartphone camera and see more accurate results.
Medical Electronics System is yet another player, offering the QwikCheckTM Semen Analysis Test Kits, a 3-level quality control material for use in automated and manual sperm counting systems. The beads it offers are for in-vitro use only, and can be used to assess the accuracy and precision of the laboratory’s sperm-counting methods by providing a new target value.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value in 2023 | US$ 990 million |
| Projected Market Value in 2033 | US$ 1,733 million |
| Growth Rate (2023 to 2033) | CAGR of 6% |
According to the latest research by Future Market Insights, the Sperm density testing market is set to witness a growth of around 6% during 2021-2031. Sperm density testing which measures and analyses the sperm count as well as the sperm health is seeing a growth in recent years.
As individuals are getting more concerned towards their health owing to increased obesity, changing lifestyles and increasing work- life imbalance taking a toll on their health. The test allows one to determine the infertility and sometimes to test for a vasectomy success.
Demand for Sperm density testing as a part of male fertility investigation on routine basis is expected to witness an optimistic growth outlook in the long run.
Cases of infertility in males can be seen rising due to various factors which are interlinked such as obesity which lowers testosteronsse levels required for driving sperm production, diabetes caused by obesity, smoking and alcohol consumption affecting sperm count and sperm quality and many more.
Other causes of decreased sperm concentration in males can be due to hormonal disorders and semen abnormalities such as low semen volume, poor sperm motility, morphological defects carries by sperm, and low sperm quality or high level of white blood cells in sperm. It has therefore become important for an individual planning to father a child, to address the issue of infertility to avoid any future complications.
As per World Health Organization (WHO) 2020 data, estimated 48 Mn couples and 186 Mn individuals are living with infertility issues.
Understanding of the magnitude and increasing prevalence of male infertility and associated challenges demands for increases testing and early determination of factors associated with it. This is likely to boost the demand for the sperm density testing market in the forecasted period.
The access to fertility care which includes preventing, diagnosing and treating the infertility, remains a major concern in most of the low and middle income countries. On the other hand, lack of trained personnel, required equipment needed for testing, high treatment medicine cost and poor health financing has turned out to be the major roadblock for countries addressing the needs of people with infertility.
Educating and raising awareness amongst people in regards to understanding the importance of treating infertility has become important. Along with various testing methods, the availability of treatment to treat low sperm count such as surgery, assisted reproductive technology (ART) and hormone treatment and medication, is likely to boost the confidence of individuals seeking treatments. The sperm density testing market is thus, expected to grow in the forecast period.
North America market growth is largely driven by increasing number of individuals affected with infertility issues. Factors such as advancements in education, late marriage, delayed child bearing, increasing cases of obesity and decreased family sizes have all impacted to this increasing figure.
As per Centers for Disease Control and Prevention (CDC) report, in USA, more than 440 clinics provide services pertaining to infertility to people seeking treatment.
As per CDC 2017 report, nearly 2% of live births in USA are due to the ART (Assisted Reproductive Technology) treatment, which is increasing further by 5% to 10% every year.
As per The Lancet report in 2020, around 8-10% of couples are affected by infertility globally while in 50% of those cases, male infertility has been the main cause.
Nearly 25% of the couples interviewed are unaware of their infertility related issues, while 60% mentioned to have received infertility treatment or IVF or medications as per Singlecare’s infertility survey, 2020.
Continuous technological advancements and development of advanced, easy-to-use, more accurate yet low cost testing devices along with increasing awareness regarding fertility testing amongst men are expected to further improve the market scenario of sperm density testing. It is believed to promote the growth of the market in the forecasted period.
Europe is anticipated to be the largest market for sperm density testing. Growing advancement in the field of diagnostics and treatment for male infertility, possibility of identifying correcting defects through genetic testing and microsurgeries and presence of key market players in the European region will facilitate the growth of the market in the forecasted period.
Some of the key players of Sperm density testing include
others Companies offering Sperm density testing are involved in existing product upgrades, new product launches, mergers and collaborations to enhance their market position.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Explore Similar Insights
Sperm Density Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
